[Federal Register Volume 88, Number 116 (Friday, June 16, 2023)]
[Notices]
[Page 39432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-12963]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the National Institute for Communicable Diseases, Republic of South 
Africa

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $2,000,000, with an expected total funding of 
approximately $11,500,000 over a five-Year period, to the National 
Institute for Communicable Diseases, Republic of South Africa. The 
award will support research studies on influenza and other respiratory 
pathogens of public health import in South Africa.

DATES: The period for this award will be September 1, 2024 through 
August 31, 2029.

FOR FURTHER INFORMATION CONTACT: Dr. Amy Yang, National Center for HIV, 
Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control 
and Prevention, 1600 Clifton Road NE, Mailstop US8-1, Atlanta, Georgia 
30329 Telephone: 404-718-8836. Email: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will conduct 
research on surveillance (including epidemiology, disease burden, 
transmission, and laboratory methods), preventive tools and strategies 
(e.g., vaccines, antivirals), and strategies for increasing coverage of 
morbidity and mortality mitigating interventions. Data will be used to 
inform prioritization of public health interventions in high-risk 
populations in South Africa, regionally and globally.
    The National Institute for Communicable Diseases is in a unique 
position to conduct this work, as it is the only sufficiently advanced 
governmental research, public health institute, and laboratory in the 
sub-region that can perform sophisticated studies and laboratory 
analyses required to understand influenza disease burden, evaluate 
intervention efficacy and effectiveness, and intervention scale-up that 
is in the Southern Hemisphere.

Summary of the Award

    Recipient: National Institute for Communicable Diseases, Republic 
of South Africa
    Purpose of the Award: The purpose of this award is to conduct 
research studies on influenza and other respiratory pathogens of public 
health import in South Africa, specifically, focusing on surveillance 
(including epidemiology, disease burden, transmission, and laboratory 
methods), preventive tools and strategies (e.g., vaccines, antivirals), 
and strategies for increasing coverage of morbidity and mortality 
mitigating interventions. Data will be used to inform prioritization of 
public health interventions in high-risk populations in South Africa, 
regionally and globally.
    Amount of Award: $2,000,000 in Federal fiscal year (FFY) 2024 
funds, with a total estimated $11,500,000 for the 5-year period of 
performance, subject to availability of funds.
    Authority: This program is authorized under Public Health Service 
Act, section 307 [42 U.S.C. 242l], as amended.
    Period of Performance: September 1, 2024 through August 31, 2029.

    Dated: June 13, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2023-12963 Filed 6-15-23; 8:45 am]
BILLING CODE 4163-18-P